Mark Laughlin
Regeneron (United States)(US)
Publications by Year
Research Areas
HIV Research and Treatment, Antifungal resistance and susceptibility, Cholinesterase and Neurodegenerative Diseases, HIV/AIDS Research and Interventions, Alzheimer's disease research and treatments
Most-Cited Works
- → Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide(1991)519 cited
- → Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults(2003)324 cited
- → Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults(2003)299 cited
- → Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial(2008)293 cited
- → CD4-independent infection of human neural cells by human immunodeficiency virus type 1(1989)290 cited
- → Oral Bioavailability of Posaconazole in Fasted Healthy Subjects(2005)208 cited
- → Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study(2004)196 cited
- → Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men(2004)154 cited
- → Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.(1994)153 cited
- → Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal Disease(2005)126 cited